Drug Approval Package
Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package
  • Print
  • Share
  • E-mail
-

 Children's ElixSure IB (Ibuprofen) Oral Suspension
Company: Taro Pharmaceuticals Inc.
Application No.:  021604
Approval Date: 01/07/2004

 

Date created: October 132006

Back to Top    Drugs@FDA

 

Note: Documents in PDF format require the Adobe Acrobat Reader®.

-
-